Moderna, Inc.

Moderna Misses on EPS, Stock Down 6.52%

Moderna's significant EPS miss indicates challenges in its financial performance this quarter, contributing to a 6.52% drop in stock price. Investors may be concerned about the company's profitability and future outlook, especially given the lack of revenue details and guidance. The market reaction reflects uncertainty surrounding Moderna's current position and future prospects.